RT Journal Article
SR Electronic
T1 Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003220
DO 10.1136/jitc-2021-003220
VO 9
IS 8
A1 Patel, Sapna P
A1 Petroni, Gina R
A1 Roszik, Jason
A1 Olson, Walter C
A1 Wages, Nolan A
A1 Chianese-Bullock, Kimberly A
A1 Smolkin, Mark
A1 Varhegyi, Nikole
A1 Gaughan, Elizabeth
A1 Smith, Kelly T
A1 Haden, Kathleen
A1 Hall, Emily H
A1 Gnjatic, Sacha
A1 Hwu, Patrick
A1 Slingluff, Craig L
YR 2021
UL http://jitc.bmj.com/content/9/8/e003220.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.